Gene expression profiles of ovarian serous carcinoma after neoadjuvant chemotherapy

被引：0
|
作者：
Shaw, PA [1 ]
Agochiya, M [1 ]
Sharma, M [1 ]
Murphy, J [1 ]
Rosen, B [1 ]
Brown, TJ [1 ]
Begley, H [1 ]
Jurisica, I [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
907
引用
收藏
页码：195A / 196A
页数：2
相关论文
共 50 条
  • [31] External validation of a 'response score' after neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma with complete clinical response
    Zorzato, Pier Carlo
    Zannoni, Gian Franco
    Tudisco, Riccardo
    Pasciuto, Tina
    Di Giorgio, Andrea
    Franchi, Massimo
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (01) : 67 - 73
  • [32] The role of neoadjuvant chemotherapy in advanced ovarian carcinoma
    Vergote, IB
    De Wever, I
    Tjalma, W
    Van Gramberen, M
    Van Dam, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S305 - S305
  • [33] FYN expression is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Uchikura, Eijiro
    Fukuda, Takeshi
    Noda, Takuya
    Awazu, Yuichiro
    Nanno, Shigenori
    Imai, Kenji
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A206 - A207
  • [34] Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers
    Jazaeri, AA
    Avvtrey, CS
    Chandramouli, GVR
    Chuang, YE
    Khan, J
    Sotiriou, C
    Aprelikova, O
    Yee, CJ
    Zorn, KK
    Birrer, MJ
    Barrett, JC
    Boyd, J
    CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6300 - 6310
  • [35] Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy
    Dressman, HK
    Hans, C
    Bild, A
    Olson, JA
    Rosen, E
    Marcom, PK
    Liotcheva, VB
    Jones, EL
    Vujaskovic, Z
    Marks, J
    Dewhirst, MW
    West, M
    Nevins, JR
    Blackwell, K
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 819 - 826
  • [36] Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
    Zorn, KK
    Bonome, T
    Gangi, L
    Chandramouli, GVR
    Awtrey, CS
    Gardner, GJ
    Barrett, JC
    Boyd, J
    Birrer, MJ
    CLINICAL CANCER RESEARCH, 2005, 11 (18) : 6422 - 6430
  • [37] Analysis of prognostic markers in serous ovarian cancer following neoadjuvant chemotherapy
    Mathur, S. R.
    Khandakar, B.
    Kumar, L.
    Kumar, S.
    Iyer, V. K.
    Gupta, S. Datta
    HISTOPATHOLOGY, 2012, 61 : 106 - 107
  • [38] Improvement of radiological disease on CT after neoadjuvant chemotherapy may not correlate with chemotherapy response score (CRS) in advanced tubo-ovarian high-grade serous ovarian carcinoma
    Sugrue, R.
    James, K.
    Growdon, W. B.
    Clark, R. M.
    del Carmen, M. G.
    Melamed, A.
    Bregar, A. J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 110 - 111
  • [39] Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma
    Price, FV
    Amin, RM
    Sumkin, J
    GYNECOLOGIC ONCOLOGY, 1999, 73 (01) : 140 - 144
  • [40] Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
    Khandakar, Binny
    Mathur, Sandeep R.
    Kumar, Lalit
    Kumar, Sunesh
    Gupta, Siddhartha Datta
    Iyer, Venkateswaran K.
    Kalaivani, M.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
12345